The U.S. government named 15 drugs that will be subject to the second round of price negotiations by Medicare, including ...

Medicare will soon start paying lower prices for Novo Nordisk’s weight- loss drug Wegovy and its Type 2 diabetes treatment ...

The Affordable Care Act (ACA) led to reductions in out-of-pocket costs and improvements in health among adults entering ...

Stock prices for Novo Nordisk fell by about 3% at market open after the Biden administration selected its revolutionary drugs ...

The Centers for Medicare & Medicaid Services on Friday released an informational bulletin with updated federal poverty level ...

Semaglutide (Ozempic) is 1 of 15 medications that will be included in yearly price negotiations between Medicare and ...

Walgreens plans to close 1,200 stores over three years. After 70 closed September to November 2024, 450 more will close in ...

The U.S. Department of Health and Human Services (HHS), through the Centers for Medicare & Medicaid Services (CMS), has ...

Medicare has announced 15 new drugs up for price negotiations, set to begin in the next several months with top drugmakers, ...

On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in ...

Blockbuster weight loss drug Ozempic could get cheaper by 2027, as it's on the list of medications the government is targeting for price negotiations this year.

The White House on Friday said Novo Nordisk's weight-loss drugs Wegovy and Ozempic were among the 15 medications picked for a round of price negotiations with Medicare. The companies do not have to ...